Search Results for "liraglutide"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for liraglutide. Results 31 to 33 of 33 total matches.
See also: Victoza
Expanded Table: Some Available Insulins for Type 2 Diabetes (online only)
The Medical Letter on Drugs and Therapeutics • May 06, 2019 (Issue 1571)
Insulin degludec/liraglutide –
Xultophy (Novo Nordisk)
100 units/3.6 mg/mL 3 mL prefilled pens Insulin ...
View the Expanded Table: Some Available Insulins
In Brief: Finerenone (Kerendia) for Diabetic Kidney Disease
The Medical Letter on Drugs and Therapeutics • Jan 23, 2023 (Issue 1668)
cardiovascular benefits
(dulaglutide, liraglutide, or subcutaneous semaglutide) can be used if
an SGLT2 ...
Recently published guidelines from the American
Diabetes Association (ADA) and the Kidney Disease:
Improving Global Outcomes (KDIGO) Diabetes Work
Group recommend addition of the oral nonsteroidal
mineralocorticoid receptor antagonist (MRA)
finerenone (Kerendia) to standard treatment in
patients with type 2 diabetes and chronic kidney
disease (CKD).
Med Lett Drugs Ther. 2023 Jan 23;65(1668):15-6 doi:10.58347/tml.2023.1668e | Show Introduction Hide Introduction
Contrave - A Combination of Bupropion and Naltrexone for Weight Loss
The Medical Letter on Drugs and Therapeutics • Nov 10, 2014 (Issue 1455)
receptor agonist liraglutide, which is
approved for treatment of type 2 diabetes as Victoza,
is currently ...
The FDA has approved a fixed-dose combination of
the opioid receptor antagonist naltrexone (ReVia, and
others) and the antidepressant and smoking cessation
agent bupropion (Wellbutrin SR, Zyban, and others),
as Contrave (Orexigen/Takeda) for weight loss. The
combination was approved for use as an adjunct to
diet and increased physical activity in patients with a
body mass index (BMI) ≥30 kg/m2 or a BMI ≥27 kg/m2
and one or more weight-related comorbidities such as
hypertension, diabetes, or dyslipidemia. Naltrexone/bupropion is not a controlled...